FDA and CTTI Hold Joint Workshop on AI in Drug Development –AI: The Washington Report | Mintz
The head of the FDA's Center for Drug Evaluation and Research, Patrizia Cavazzoni, stated that the agency is currently draftingrisk-based guidance on …
- Topics
- HealthcareMarkets & InvestmentGovernment & Public Sector
- Mentions
- FDA
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”